TMCnet News
Worldwide Market for Liquid Biopsy - Analysis, Technologies & Forecasts - Research and MarketsThe "The Worldwide Market for Liquid Biopsy (by Analyte [ctDNA, cfDNA, Other], by Application - Screening/Drug Monitoring/Diagnostic, by Region [US, Europe, Asia, ROW] and by Type of Cancer)" report has been added to Research and Markets' offering. The term liquid biopsy encompasses various diagnostic methods that use liquid, non-tissue specimens to provide information that can aid in the diagnosis, treatment and monitoring of cancer. Currently, tissue biopsies, along with imaging techniques, are the standard methods used in the diagnosis of solid cancers, but despite their widespread use, they have many limitations that open the door for other diagnostic technologies in oncology clinical settings. The Worldwide Market for Liquid Biopsy Contains Markets for the Following:
Companies Mentioned
Key Topics Covered: 1: Executive Summary 2: Liquid Biopsy Technologies 3: Circulating Tumor Dna (Cfdna) Liquid Biopsy 4: Circulating Tumor Cells (Ctcs) Liquid Biopsy 5: Extracellular Vesicles And Other Liquid Biopsy 6: Liquid Biopsy Industry Analysis 7: Liquid Biopsy Market Size And Forecast 8: Market By Type Of Analyte 9: Market By Type Of Application For more information about this report visit https://www.researchandmarkets.com/research/ch6ln4/the_worldwide
View source version on businesswire.com: http://www.businesswire.com/news/home/20170804005443/en/ |